CIR Vaccine Trials – Currently Enrolling

Project SAVE (Support a Vaccine Effort) is the adult recruitment program at the Center for Immunization Research.  The program is used to screen adult potential study participants to help determine their eligibility for specific clinical vaccine studies at the CIR.  Check below for studies that are currently enrolling.

Inpatient

Zika Vaccine Inpatient Study (CIR 316)

The purpose of this study is to learn about the clinical presentation and duration of shedding of the Zika virus in healthy adults.  The study is:

  • 6 months long
  • enrolling FEMALES ONLY 18-40 years old
  • includes 2-3 screening visits, one 16 day inpatient stay and 11 outpatient follow up visits
  • pays up to $5025 for completion of all study procedures

Complete the Pre-Screening Survey to see if you qualify for an in-person screening visit

Complete the CIR Contact Form to be contacted by a CIR staff member

More about  Zika Virus

Learn More

Outpatient

COVID/Flu Vaccine Study (CIR 348)

The purpose of this study is to test the safety of receiving a quadrivalent inactivated influenza (flu) vaccine and an mRNA COVID-19 vaccine on the same day or two weeks apart. The study (is):

  • enrolling people 12 and older
  • 4 months long
  • includes 1 phone screening, 3 vaccination day visits, 2 in-person follow-up visits and 4 phone follow-up visits.
  • pays up to $425

Complete the CIR Contact Form 

More about Flu

More about COVID

Learn More
Shingrix and Flu Vaccine Study (CIR 345)

This research study aims to compare the safety of administering Shingrix (shingles vaccine) at the same time as FLUAD or Fluzone High-Dose influenza vaccines in older people.  The study (is):

  • enrolling people 65 years old and older
  • 3.5 months long
  • includes 4 clinic visits and 5 phone calls
  • pays up to $325
  • offers Shingriz and Flu vaccines free of charge for people who are enrolled

Complete the CIR Contact Form 

More about Flu

Learn More
Dose Study to Protect Against Dengue Virus (CIR 332)

The purpose of this study is to evaluate the safety and efficacy of repeated oral doses to protect against exposure to dengue virus.  The study (is):

  • enrolling people 18-55 years old
  • 3 months long
  • 2-3 screening visits
  • visits every other day for one month
  • 1 two-night inpatient stay
  • 1 Dengue challenge visit
  • 8 follow up visits
  • pays up to $4165 for completion of all study procedures

Complete the Pre-Screening Survey to see if you qualify for an in-person screening visit

Complete the CIR Contact Form to be contacted by a CIR staff member

More about Dengue Virus

Learn More
Translate »